Skip to content

Clinical trials

Phase 3 Lupus Nephritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Nephritis Phase: Phase 3 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20121
20131
20171
20191
20202
20223
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Active, not recruiting3
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aurinia Pharmaceuticals Inc.4
Novartis Pharmaceuticals3
Hoffmann-La Roche2
La Jolla Pharmaceutical Company2
AstraZeneca1
Bristol-Myers Squibb1
Human Genome Sciences Inc., a GSK Company1
Vera Therapeutics, Inc.1
Viatris Innovation GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Nephritis16
Lupus Erythematosus, Systemic8
Nephritis3
Autoimmune Diseases2
Glomerulonephritis1
Immune System Diseases1
Kidney Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.